Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 2
2013 1
2014 3
2015 1
2016 1
2017 1
2018 1
2019 2
2020 1
2021 1
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.
Rudin CM, Pandha HS, Zibelman M, Akerley WL, Harrington KJ, Day D, Hill AG, O'Day SJ, Clay TD, Wright GM, Jennens RR, Gerber DE, Rosenberg JE, Ralph C, Campbell DC, Curti BD, Merchan JR, Ren Y, Schmidt EV, Guttman L, Gupta S. Rudin CM, et al. Among authors: clay td. J Immunother Cancer. 2023 Jan;11(1):e005007. doi: 10.1136/jitc-2022-005007. J Immunother Cancer. 2023. PMID: 36669791 Free PMC article. Clinical Trial.
Doctors' understanding of consent law.
Skiba R, Sikotra N, Wilson A, Clay TD, Gabbay E. Skiba R, et al. Among authors: clay td. Intern Med J. 2021 Jul;51(7):1068-1073. doi: 10.1111/imj.14873. Intern Med J. 2021. PMID: 32358854
Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancer.
Kim JS, Taaffe DR, Galvão DA, Clay TD, Redfern AD, Hart NH, Gray ES, Ryan CJ, Kenfield SA, Saad F, Newton RU. Kim JS, et al. Among authors: clay td. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):795-801. doi: 10.1038/s41391-022-00624-4. Epub 2022 Nov 29. Prostate Cancer Prostatic Dis. 2023. PMID: 36446945
LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC.
Alexander M, Wei J, Parakh S, John T, Kao S, Nagrial A, Bowyer S, Warburton L, Moore M, Hughes BGM, Clay TD, Pavlakis N, Solomon BJ, Itchins M. Alexander M, et al. Among authors: clay td. JTO Clin Res Rep. 2023 Feb 26;4(4):100490. doi: 10.1016/j.jtocrr.2023.100490. eCollection 2023 Apr. JTO Clin Res Rep. 2023. PMID: 37077199 Free PMC article.
20 results